Roche’s innovative product pipeline is one of the most impressive in the pharmaceuticals sector. It has over 100 research projects and more than 60 NMEs, or New Molecular Entities (New Molecular Entities), in development. Roche has nine research centers on three continents and invests nearly $9 billion annually in research. Roche’s Nutley in New Jersey will soon be the second-largest global research center due to its current expansion.
“Roche Nutley is a science-centered organization which encourages innovation and entrepreneurship and is experiencing growth in these tumultuous times,”Marcia Geremakis (director, Human Resources Roche Pharma Research Nutley, N.J.)
Roche is expanding its Nutley facility for research with a special focus in oncology, inflammation, metabolic disease, and RNAi therapies. It intends to continue to employ world-class scientists at the Nutley facility. Roche and Genentech are currently integrating U.S. operations. This opens up the possibility for scientists to join Roche as they begin a new chapter. Roche will also be adding 120 positions to the company’s next year, approximately 50 of which are in inflammation.
Roche Pharma Research, Nutley, has a long history of creating innovative medicines. The research activities focus on developing clinically differentiated medicines using small molecules (chemical compounds), therapeutic proteins (mainly monoclonal antibodies and peptides) and glycoengineering. Roche is currently exploring small interfering ribonucleic Acid molecules (also known by RNA interference or RNAi), a promising strategy that relies on targeted gene silencing (turning genes ON or OFF) and which is hoped to lead to new therapeutic options.
Roche’s strong funding, increased investment in R&D and entrepreneurial, creative environment make the company an ideal organization where scientists can devote much of their time to science and see their work make a difference in patients’ lives.
Roche has been recognized over the past ten years as a great workplace by numerous publications including Science magazine and FORTUNE. The company was also listed among AARP’s Top 50 Companies for Workers Over 50.
For more information on careers at Roche, visit http://careers.roche.com/.
